These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31213911)

  • 1. Loss of ARID1A promotes proliferation, migration and invasion via the Akt signaling pathway in NPC.
    Yang Y; Wang X; Yang J; Duan J; Wu Z; Yang F; Zhang X; Xiao S
    Cancer Manag Res; 2019; 11():4931-4946. PubMed ID: 31213911
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1.
    Zhang Q; Yan HB; Wang J; Cui SJ; Wang XQ; Jiang YH; Feng L; Yang PY; Liu F
    Oncotarget; 2016 Jul; 7(29):46127-46141. PubMed ID: 27323812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma.
    Wu M; Ye X; Deng X; Wu Y; Li X; Zhang L
    Onco Targets Ther; 2016; 9():1647-56. PubMed ID: 27051300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells.
    Lee D; Yu EJ; Ham IH; Hur H; Kim YS
    Onco Targets Ther; 2017; 10():4153-4159. PubMed ID: 28860825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency
    Yang L; Yang G; Ding Y; Dai Y; Xu S; Guo Q; Xie A; Hu G
    J Cancer; 2018; 9(5):890-900. PubMed ID: 29581767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
    Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
    J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X; Jin Q; Wang X; Chen W; Cai Z
    Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription.
    Yan HB; Wang XF; Zhang Q; Tang ZQ; Jiang YH; Fan HZ; Sun YH; Yang PY; Liu F
    Carcinogenesis; 2014 Apr; 35(4):867-76. PubMed ID: 24293408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of NACC1 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via regulating the AKT/mTOR signaling pathway.
    Cao Z; Chen H; Mei X; Li X
    Oncol Lett; 2021 Dec; 22(6):828. PubMed ID: 34691255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma.
    Cai Y; Lai Q; Zhang X; Zhang Y; Zhang M; Gu S; Qin Y; Hou J; Zhao L
    Korean J Physiol Pharmacol; 2023 Sep; 27(5):457-470. PubMed ID: 37641808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Ezrin suppresses cell migration and invasion in human nasopharyngeal carcinoma.
    Tang Y; Sun X; Yu S; Bie X; Wang J; Ren L
    Oncol Lett; 2019 Jul; 18(1):553-560. PubMed ID: 31289527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway.
    Feng G; Arima Y; Midorikawa K; Kobayashi H; Oikawa S; Zhao W; Zhang Z; Takeuchi K; Murata M
    Cancer Cell Int; 2023 Aug; 23(1):185. PubMed ID: 37644594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells.
    Zhang P; Ma J; Gao J; Liu F; Sun X; Fang F; Zhao S; Liu H
    J Bioenerg Biomembr; 2018 Aug; 50(4):271-281. PubMed ID: 29882205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
    Yang Y; Li Q; Guo L
    Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.